The Federal Trade Commission said Friday that it is suing three drug middlemen, accusing them of inflating insulin prices.
Pfizer's and Moderna's formulas have been the go-to on pharmacy shelves, but Novavax remains an important option.
The agency says the companies artificially inflated insulin list prices that resulted in patients paying more for the medications. The companies are CVS Health’s Caremark RX, Cigna’s Express Scripts, ...
The Federal Trade Commission alleges that pharmacy benefits managers prioritized high rebates from drug makers for insulin over lower prices for consumers, leading to inflated out-of-pocket costs.
On Friday, the Federal Trade Commission (FTC) filed a formal complaint against three major pharmacy benefit managers ...
FTC sues top PBMs for inflating insulin prices, accusing them of rigging competition and hurting patients. Legal action also includes GPOs.
The Federal Trade Commission has accused three major pharmacy benefit managers of inflating insulin prices, the agency said ...
Three companies that process about 80% of prescriptions in the United States — Caremark, Express Scripts and OptumRx — have ...
The Federal Trade Commission (FTC) on Friday sued the three largest pharmacy benefit managers (PBMs) for engaging in alleged ...
Millions of Americans with diabetes need insulin to survive, yet for many of these vulnerable patients, their insulin drug ...
The FTC said CVS Caremark, Cigna’s Express Scripts, and UnitedHealth’s OptumRx profit at the expense of patients forced to ...
The case takes aim at the major pharmacy benefit managers, agency officials said, claiming that they favored more expensive ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback